Douglas Kyle Hogarth to Antibodies, Monoclonal
This is a "connection" page, showing publications Douglas Kyle Hogarth has written about Antibodies, Monoclonal.
Connection Strength
0.019
-
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18; 31(1):46-54.
Score: 0.019